Sense or 'nonsense'? Senators blast Lilly's generic insulin, but CEO Ricks strikes back

18th December 2019 Uncategorised 0

A high-profile report out of the U.S. Senate this week concluded Eli Lilly’s generic version of its big-selling insulin Humalog just hasn’t delivered for patients. Many pharmacies don’t even offer it, the senators found. But Lilly CEO David Ricks called the report “nonsense.”

More: Sense or 'nonsense'? Senators blast Lilly's generic insulin, but CEO Ricks strikes back
Source: fierce